LOAMU
GBT

Lombard Odier Asset Management (USA)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,000
Closed -$1.02M – 472
2022
Q3 		$1.02M Buy
+15,000
New +$827K 0.03% 214

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s GBT Position: Q4 2022 in Review

Lombard Odier Asset Management (USA) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 15,000 shares — an estimated $1.02M sold.

Lombard Odier Asset Management (USA) first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $1.02M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Lombard Odier Asset Management (USA) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 15,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.02M.
  • Lombard Odier Asset Management (USA) first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Global Blood Therapeutics, Inc. position peaked at $1.02M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.